Comparative Effects of Under Water Exercise and Radial Extracorporeal Shockwave Therapy on Lower-Limb Spasticity, Gross Motor Function, and Quality of Life in Children With Spastic Diplegic Cerebral Palsy: A Randomized Controlled Trial
spastic CP
spastic CP
Sponsor study identifier
interventional
60
1 country
1
Study Start
February 10, 2024
Actual (reported)Primary Completion
August 22, 2025
Actual (reported)Study Completion
September 8, 2025
Actual (reported)Children with spastic diplegic cerebral palsy often present with lower-limb spasticity, limited gross motor function, and reduced quality of life. Effective interventions are needed to improve functional outcomes and daily participation.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 8, 2025
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
February 10, 2024
Actual (reported)August 22, 2025
Actual (reported)September 8, 2025
Actual (reported)October 11, 2026
Actual (reported)October 16, 2026
Actual (reported)1- Modified Ashworth Scale (MAS)
The MAS measures the muscle group's resistance to passive stretching on a six-point ordinal scale that ranges from 0 (no increase in muscle tone) to 4. A score of 1 indicates a slight increase in muscle tone with a catch and release, whereas a score of 2 indicates a more notable increase in muscle tone across the range of motion. A score of 3 shows a significant increase in muscle tone; passive movement is complex, and there is a "catch" at a particular place in the range of motion. A score of 4 represents stiff flexion or extension.
12 weeks
2- The Gross Motor Function Measure-66 (GMFM-66)
12 weeks
3- Pediatric Quality of Life Inventory (PedsQL)
12 weeks
Aquatic Neuromotor Repatterning Program (ANRP)
Targeted Neuromodulatory Shockwave Protocol (TNMSP)
Underwater exercise was conducted five times per week for 12 weeks. Each session took place for 60 minutes in a therapy pool with water temperatures between 33-35°С. The water depth ranged from chest deep to waist deep, depending on the functional level and progress of each participant. Sessions were structured into five parts. Each session began with 10 minutes of warm-up consisting of water walking with support, slow water marching, and body awareness exercises using aquatic foam noodles. After the warm-up, patients spent 15 minutes practicing neuromotor control in buoyancy. The goals of this portion were to reduce co-contraction of muscles and increase ability to have selective motor control.
Contact the study team to confirm eligibility.
Bassam Ahmed Nabil
October 6 City, Cairo Governorate, 78345, Egypt
60 participants (actual enrollment reported by the registry).
First Submitted
October 11, 2026
First Posted
October 16, 2026
Study Start
February 10, 2024
Actual (reported)Group B received a Targeted Neuromodulatory Shockwave Protocol (TNMSP). The protocol involves the combined application of extracorporeal shockwave therapy (ESWT) and the targeted immediate functional activation. The rationale behind the treatment is the concept that spasticity reduction achieved through the use of ESWT would facilitate enhanced motor learning and promote the emergence of normal motor patterns. The intervention was lasted for 12 weeks and involved 1 ESWT and 2 functional activation sessions weekly. The ESWT component of the protocol was selected to maximize the neuromodulatory potential by promoting plasticity within the central nervous system and to consolidate the motor patterns introduced during the functional activation
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Primary Completion
August 22, 2025
Actual (reported)Study Completion
September 8, 2025
Actual (reported)Last Updated
October 16, 2026
Record last verified: 2026-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: